Related Experiment Video

Updated: Jun 26, 2026

Use of Artificial Sputum Medium to Test Antibiotic Efficacy Against Pseudomonas aeruginosa in Conditions More Relevant to the Cystic Fibrosis Lung
07:46

Use of Artificial Sputum Medium to Test Antibiotic Efficacy Against Pseudomonas aeruginosa in Conditions More Relevant to the Cystic Fibrosis Lung

Published on: June 5, 2012

Spiramycin: a reappraisal of its antibacterial activity

R Sutherland

    British Journal of Pharmacology and Chemotherapy
    |December 25, 2008
    PubMed

    Insights

    Spiramycin showed comparable effectiveness to erythromycin against Staphylococcus aureus infections in mice. However, spiramycin demonstrated superior efficacy against erythromycin-resistant strains, likely due to its prolonged tissue persistence.

    Area of Science:

    • Microbiology
    • Pharmacology
    • Infectious Diseases

    Background:

    • Staphylococcus aureus infections pose a significant health threat.
    • Macrolide antibiotics like erythromycin and spiramycin are used to treat bacterial infections.
    • Understanding the comparative efficacy and resistance patterns of these antibiotics is crucial for effective treatment.

    Purpose of the Study:

    • To compare the in vitro and in vivo activity of spiramycin and erythromycin against Staphylococcus aureus.
    • To investigate the cross-resistance patterns between spiramycin and erythromycin.
    • To determine the pharmacokinetic profiles of spiramycin and erythromycin in mice.

    Main Methods:

    • In vitro susceptibility testing of Staphylococcus aureus strains against spiramycin and erythromycin.
    • In vivo efficacy studies in mouse models of staphylococcal infection.
    • Pharmacokinetic analysis of drug distribution in mouse serum and tissues.

    Main Results:

    • Spiramycin was less active than erythromycin in vitro against sensitive S. aureus strains.
    • Both antibiotics were equally effective when administered immediately post-infection in mice.
    • Spiramycin showed greater prophylactic efficacy and was more effective against erythromycin-resistant strains in vivo.
    • Spiramycin exhibited higher and more prolonged tissue concentrations compared to erythromycin in mice.

    Conclusions:

    • Spiramycin's persistence in animal tissues contributes to its efficacy against experimental staphylococcal infections.
    • Spiramycin may be a valuable therapeutic option for infections caused by erythromycin-resistant Staphylococcus aureus.
    • Further research is warranted to explore spiramycin's clinical utility.

    More Related Videos

    Synthesis of Masarimycin, a Small Molecule Inhibitor of Gram-Positive Bacterial Growth09:10

    Synthesis of Masarimycin, a Small Molecule Inhibitor of Gram-Positive Bacterial Growth

    Published on: January 7, 2022

    Related Concept Videos

    Inhibitors of Bacterial Protein Synthesis01:25

    Inhibitors of Bacterial Protein Synthesis

    Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
    Clinical Significance of Antibiotic Resistance01:25

    Clinical Significance of Antibiotic Resistance

    Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
    Mechanism of Antibiotic Resistance in MRSA01:25

    Mechanism of Antibiotic Resistance in MRSA

    Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
    Combined Effects of Drugs: Synergism01:27

    Combined Effects of Drugs: Synergism

    Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
    Such synergistic combinations...
    Antimicrobial Effectiveness01:28

    Antimicrobial Effectiveness

    The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...